Dyfyniad APA

Andrés Cerezo, L., Šumová, B., Prajzlerová, K., Veigl, D., Damgaard, D., Nielsen, C. H., . . . Šenolt, L. (2017). Calgizzarin (S100A11): A novel inflammatory mediator associated with disease activity of rheumatoid arthritis. Arthritis Res Ther.

Dyfyniad Arddull Chicago

Andrés Cerezo, Lucie, Barbora Šumová, Klára Prajzlerová, David Veigl, Dres Damgaard, Claus Henrik Nielsen, Karel Pavelka, Jiří Vencovský, and Ladislav Šenolt. "Calgizzarin (S100A11): A Novel Inflammatory Mediator Associated With Disease Activity of Rheumatoid Arthritis." Arthritis Res Ther 2017.

Dyfyniad MLA

Andrés Cerezo, Lucie, et al. "Calgizzarin (S100A11): A Novel Inflammatory Mediator Associated With Disease Activity of Rheumatoid Arthritis." Arthritis Res Ther 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.